Related Experiment Video
Updated: Jun 10, 2026
07:13
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Comparative effectiveness research: evaluating pharmacist interventions and strategies to improve medication
Barry L Carter1, J W Foppe van Mil
1Department of Pharmacy Practice and Science, College of Pharmacy, Iowa City, Iowa, USA. barry-carter@uiowa.edu
American Journal of Hypertension
|July 24, 2010
Summary
Physician and pharmacist collaboration effectively controls blood pressure (BP). Pharmacy interventions improve medication adherence and intensify treatments, but study designs and suboptimal regimens need improvement for better BP management.
Area of Science:
- Health Services Research
- Cardiovascular Medicine
- Pharmacy Practice
Background:
- Achieving optimal blood pressure (BP) control is a significant challenge in primary care.
- Physician/pharmacist collaborative management is an effective strategy for BP control.
- Pharmacy interventions can improve medication adherence and treatment intensification.
Purpose of the Study:
- To evaluate the strengths and weaknesses of research study designs assessing pharmacy interventions for BP control.
- To assess strategies for measuring medication adherence in research and clinical practice.
- To propose improvements for interventions and study designs in team-based care for BP control.
Main Methods:
- Review of health services' research study designs.
- Evaluation of medication adherence measurement strategies.
- Analysis of pharmacy interventions in primary care settings.
Main Results:
- Pharmacy interventions significantly reduce BP through improved adherence and medication intensification.
- Suboptimal medication regimens are a common cause of inadequate BP control.
- Existing research designs have limitations in assessing the full impact of pharmacy interventions.
Conclusions:
- Collaborative physician/pharmacist management is key to effective BP control.
- Enhanced study designs and interventions are needed to address suboptimal regimens.
- Future research should focus on robust comparative effectiveness trials for team-based BP management.
Related Concept Videos
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:28Dosage Regimens: Designs and Approaches
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
01:20Measurement of Bioavailability: Pharmacodynamic Methods
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
01:24Pharmacokinetic–Pharmacodynamic Relationship: Problems
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...